Identifying Barriers to Cellular Therapy

Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Disorders PROACT PCD

  • Transplant Service
  • 23-166

What's the purpose of the trial?

This is an observational study that will include both participants with relapsed/refractory Multiple Myeloma and their doctors. 

Trial status

Accepting patients

Phase
Observational Trial
Enrollment
400
Last Updated
2 months ago
Patient Screener

Participating Centers

There are 7 centers participating in this trial. Enter a location below to find the closest center.

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Accepting patients

Patient Cohort 1

Accepting patients

Patient Cohort 2

Accepting patients

Physician Group 1: Primary Myeloma Therapy

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.